Cover Image
Market Research Report

Global Sensory Organ Partnering 2014-2019: Deal trends, players and financials

Published by Current Partnering, a division of Wildwood Ventures Limited Product code 263948
Published Content info 200+ Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Sensory Organ Partnering 2014-2019: Deal trends, players and financials
Published: March 1, 2019 Content info: 200+ Pages
Description

Global Sensory Organ Partnering 2014-2019: Deal trends, players and financials provides comprehensive understanding and unprecedented access to the sensory organ partnering deals and agreements entered into by the worlds leading healthcare companies

Description

Global Sensory Organ Partnering 2014 to 2019 provides the full collection of Sensory Organ disease deals signed between the world's pharmaceutical and biotechnology companies since 2014.

Trends in Sensory Organ partnering deals

Financial deal terms for headline, upfront and royalty by stage of development

Sensory Organ partnering agreement structure

Sensory Organ partnering contract documents

Top Sensory Organ deals by value

Most active Sensory Organ dealmakers

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Sensory Organ disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Sensory Organ deals.

The report presents financial deal terms values for Sensory Organ deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

The initial chapters of this report provide an orientation of Sensory Organ dealmaking trends.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in Sensory Organ dealmaking since 2014 covering trends by year, deal type, stage of development, technology type and therapeutic indication.

Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.

Chapter 4 provides a review of the leading Sensory Organ deals since 2014. Deals are listed by headline value. The chapter includes the top 25 most active Sensory Organ dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 5 provides comprehensive access to Sensory Organ deals since 2014 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of all Sensory Organ partnering deals by specific Sensory Organ target announced since 2014. The chapter is organized by specific Sensory Organ therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided with each report of all Sensory Organ partnering deals signed and announced since 2014. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Sensory Organ partnering and dealmaking since 2014.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Sensory Organ technologies and products.

Report scope

Global Sensory Organ Partnering 2014 to 2019 is intended to provide the reader with an in-depth understanding and access to Sensory Organ trends and structure of deals entered into by leading companies worldwide.

Global Sensory Organ Partnering 2014 to 2019 includes:

  • Trends in Sensory Organ dealmaking in the biopharma industry since 2014
  • Analysis of Sensory Organ deal structure
  • Access to headline, upfront, milestone and royalty data
  • Access to hundreds of Sensory Organ deal contract documents
  • Comprehensive access to over 3500 Sensory Organ deal records
  • The leading Sensory Organ deals by value since 2014
  • Most active Sensory Organ dealmakers since 2014
  • The report includes deals for the following indications: Taste disorders, Hearing disorders, Hearing loss, Meniere's disease, Smell disorders, plus other sensory indications.

In Global Sensory Organ Partnering 2014 to 2019, available deals and contracts are listed by:

  • Headline value
  • Upfront payment value
  • Royalty rate value
  • Stage of development at signing
  • Deal component type
  • Technology type
  • Specific therapy indication
  • Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Sensory Organ Partnering 2014-2019 report provides comprehensive access to available deals and contract documents for over 60 sensory organ deals. Analyzing actual contract agreements allows assessment of the following:

  • What are the precise rights granted or optioned?
  • What is actually granted by the agreement to the partner company?
  • What exclusivity is granted?
  • What is the payment structure for the deal?
  • How are the sales and payments audited?
  • What is the deal term?
  • How are the key terms of the agreement defined?
  • How are IPRs handled and owned?
  • Who is responsible for commercialization?
  • Who is responsible for development, supply, and manufacture?
  • How is confidentiality and publication managed?
  • How are disputes to be resolved?
  • Under what conditions can the deal be terminated?
  • What happens when there is a change of ownership?
  • What sublicensing and subcontracting provisions have been agreed?
  • Which boilerplate clauses does the company insist upon?
  • Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
  • Which jurisdiction does the company insist upon for agreement law?

Benefits

Global Sensory Organ Partnering 2014 to 2019 provides the reader with the following key benefits:

  • In-depth understanding of Sensory Organ deal trends since 2014
  • Access Sensory Organ deal headline, upfront, milestone and royalty data
  • Research hundreds of actual contracts between Sensory Organ partner companies
  • Comprehensive access to over 750 links to actual Sensory Organ deals entered into by the world's biopharma companies
  • Indepth review of Sensory Organ deals entered into by the top 25 most active dealmakers
  • Benchmark the key deal terms companies have agreed in previous deals
  • Identify key terms under which companies partner Sensory Organ opportunities
  • Uncover companies actively partnering Sensory Organ opportunities
Table of Contents
Product Code: CP2217

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Sensory Organ dealmaking

  • 2.1. Introduction
  • 2.2. Sensory Organ partnering over the years
  • 2.3. Sensory Organ partnering by deal type
  • 2.4. Sensory Organ partnering by industry sector
  • 2.5. Sensory Organ partnering by stage of development
  • 2.6. Sensory Organ partnering by technology type
  • 2.7. Sensory Organ partnering by therapeutic indication

Chapter 3 -Financial deal terms for Sensory Organ partnering

  • 3.1. Introduction
  • 3.2. Disclosed financials terms for Sensory Organ partnering
  • 3.3. Sensory Organ partnering headline values
  • 3.4. Sensory Organ deal upfront payments
  • 3.5. Sensory Organ deal milestone payments
  • 3.6. Sensory Organ royalty rates

Chapter 4 - Leading Sensory Organ deals and dealmakers

  • 4.1. Introduction
  • 4.2. Most active in Sensory Organ partnering
  • 4.3. List of most active dealmakers in Sensory Organ
  • 4.4. Top Sensory Organ deals by value

Chapter 5 - Sensory Organ contract document directory

  • 5.1. Introduction
  • 5.2. Sensory Organ partnering deals where contract document available

Chapter 6 - Sensory Organ dealmaking by therapeutic target

  • 6.1. Introduction
  • 6.2. Deals by Sensory Organ therapeutic target

Appendices

  • Appendix 1 - Directory of Sensory Organ deals by company A-Z 2014 to 2019
  • Appendix 2 - Directory of Sensory Organ deals by deal type 2014 to 2019
  • Appendix 3 - Directory of Sensory Organ deals by stage of development 2014 to 2019
  • Appendix 4 - Directory of Sensory Organ deals by technology type 2014 to 2019
  • Further reading on dealmaking
  • Deal type definitions
  • About Wildwood Ventures
  • Current Partnering
  • Current Agreements
  • Recent report titles from CurrentPartnering
  • Table of figures
  • Figure 1: Sensory Organ partnering since 2014
  • Figure 2: Sensory Organ partnering by deal type since 2014
  • Figure 3: Sensory Organ partnering by industry sector since 2014
  • Figure 4: Sensory Organ partnering by stage of development since 2014
  • Figure 5: Sensory Organ partnering by technology type since 2014
  • Figure 6: Sensory Organ partnering by indication since 2014
  • Figure 7: Sensory Organ deals with a headline value
  • Figure 8: Sensory Organ deals with upfront payment values
  • Figure 9: Sensory Organ deals with milestone payment
  • Figure 10: Sensory Organ deals with royalty rates
  • Figure 11: Active Sensory Organ dealmaking activity- 2014 to 2019
  • Figure 12: Top Sensory Organ deals by value since 2014
Back to Top